1. Biopharma ramps up lobbying spend as drug pricing legislation nears — Roche culls two COVID-19 hopefuls amid Q1 clear-out — FDA offers scathing review of Emergent plantSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Getting Bought Out

Discussion in 'Dermira' started by anonymous, Jan 10, 2020 at 7:59 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Going to be a busy day....
     

  2. anonymous

    anonymous Guest

    It’s going to be a wipe out for both companies but in different ways.
     
  3. anonymous

    anonymous Guest

    Yana and the manager are crooks, who have a mafia money laundering service going on in a pharmacy.
     
  4. anonymous

    anonymous Guest

    Home office here. Thank you sales team for making me rich after this acquisition. Good news is you can all stop bitching when a Lilly lays you off. Unlike you we got some good equity!